These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10066756)

  • 1. Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein.
    Stafforini DM; Tjoelker LW; McCormick SP; Vaitkus D; McIntyre TM; Gray PW; Young SG; Prescott SM
    J Biol Chem; 1999 Mar; 274(11):7018-24. PubMed ID: 10066756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor.
    Stafforini DM; McIntyre TM; Carter ME; Prescott SM
    J Biol Chem; 1987 Mar; 262(9):4215-22. PubMed ID: 3549727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma.
    Stafforini DM; Carter ME; Zimmerman GA; McIntyre TM; Prescott SM
    Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2393-7. PubMed ID: 2928339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme.
    Tselepis AD; Dentan C; Karabina SA; Chapman MJ; Ninio E
    Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1764-73. PubMed ID: 7583554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced association of platelet-activating factor acetylhydrolase with lipoprotein (a) in comparison with low density lipoprotein.
    Blencowe C; Hermetter A; Kostner GM; Deigner HP
    J Biol Chem; 1995 Dec; 270(52):31151-7. PubMed ID: 8537378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-density lipoprotein inhibits the production of platelet activating factor acetylhydrolase by HepG2 cells.
    Satoh K; Imaizumi T; Yoshida H; Takamatsu S
    J Lab Clin Med; 1994 Feb; 123(2):225-31. PubMed ID: 8301198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver cells secrete the plasma form of platelet-activating factor acetylhydrolase.
    Tarbet EB; Stafforini DM; Elstad MR; Zimmerman GA; McIntyre TM; Prescott SM
    J Biol Chem; 1991 Sep; 266(25):16667-73. PubMed ID: 1653245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL.
    Tsoukatos DC; Arborati M; Liapikos T; Clay KL; Murphy RC; Chapman MJ; Ninio E
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3505-12. PubMed ID: 9437199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAF-acetylhydrolase, predominantly present in LDL in healthy subjects, is associated with HDL in a patient with LDL deficiency.
    Surya II; Mommersteeg M; Erkelens DW; Akkerman JW
    J Lipid Mediat; 1991; 3(1):27-38. PubMed ID: 1768838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAF-acetylhydrolase activity of Lp(a) before and during Cu(2+)-induced oxidative modification in vitro.
    Karabina SA; Elisaf MC; Goudevenos J; Siamopoulos KC; Sideris D; Tselepis AD
    Atherosclerosis; 1996 Aug; 125(1):121-34. PubMed ID: 8831934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The degradation of platelet-activating factor in the plasma of a patient with familial high density lipoprotein deficiency (Tangier disease).
    Pritchard PH; Chonn A; Yeung CC
    Blood; 1985 Dec; 66(6):1476-8. PubMed ID: 4063532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAF-acether-degrading acetylhydrolase in plasma LDL is inactivated by copper- and cell-mediated oxidation.
    Dentan C; Lesnik P; Chapman MJ; Ninio E
    Arterioscler Thromb; 1994 Mar; 14(3):353-60. PubMed ID: 8123638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a domain that mediates association of platelet-activating factor acetylhydrolase with high density lipoprotein.
    Gardner AA; Reichert EC; Topham MK; Stafforini DM
    J Biol Chem; 2008 Jun; 283(25):17099-106. PubMed ID: 18434304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor.
    Ambrosio G; Oriente A; Napoli C; Palumbo G; Chiariello P; Marone G; Condorelli M; Chiariello M; Triggiani M
    J Clin Invest; 1994 Jun; 93(6):2408-16. PubMed ID: 8200975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating factor acetylhydrolases: broad substrate specificity and lipoprotein binding does not modulate the catalytic properties of the plasma enzyme.
    Min JH; Wilder C; Aoki J; Arai H; Inoue K; Paul L; Gelb MH
    Biochemistry; 2001 Apr; 40(15):4539-49. PubMed ID: 11294621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.
    Watson AD; Navab M; Hama SY; Sevanian A; Prescott SM; Stafforini DM; McIntyre TM; Du BN; Fogelman AM; Berliner JA
    J Clin Invest; 1995 Feb; 95(2):774-82. PubMed ID: 7860760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma.
    Stremler KE; Stafforini DM; Prescott SM; Zimmerman GA; McIntyre TM
    J Biol Chem; 1989 Apr; 264(10):5331-4. PubMed ID: 2494162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility.
    McCall MR; La Belle M; Forte TM; Krauss RM; Takanami Y; Tribble DL
    Biochim Biophys Acta; 1999 Jan; 1437(1):23-36. PubMed ID: 9931415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase.
    Steinbrecher UP; Pritchard PH
    J Lipid Res; 1989 Mar; 30(3):305-15. PubMed ID: 2723538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis for susceptibility of plasma platelet-activating factor acetylhydrolase to oxidative inactivation.
    MacRitchie AN; Gardner AA; Prescott SM; Stafforini DM
    FASEB J; 2007 Apr; 21(4):1164-76. PubMed ID: 17210780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.